1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine

C129H144N16O13 — CID 161253262

IUPAC1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine
SMILESCCCC/N=C(\N)c1ccccc1.CCCCn1c(C=O)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)C(=O)c2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)Cc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CNCc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CO)cnc1-c1ccccc1.[H]/N=C(\C)c1ccccc1
InChIInChI=1S/C30H29N3O5.C30H31N3O4.C22H25N3O2.C14H18N2O.C14H16N2O.C11H16N2.C8H9N/c1-2-3-13-33-24(16-31-29(33)22-7-5-4-6-8-22)18-32(17-21-9-11-25-27(14-21)37-19-35-25)30(34)23-10-12-26-28(15-23)38-20-36-26;1-2-3-13-33-25(16-31-30(33)24-7-5-4-6-8-24)19-32(17-22-9-11-26-28(14-22)36-20-34-26)18-23-10-12-27-29(15-23)37-21-35-27;1-2-3-11-25-19(15-24-22(25)18-7-5-4-6-8-18)14-23-13-17-9-10-20-21(12-17)27-16-26-20;2*1-2-3-9-16-13(11-17)10-15-14(16)12-7-5-4-6-8-12;1-2-3-9-13-11(12)10-7-5-4-6-8-10;1-7(9)8-5-3-2-4-6-8/h4-12,14-16H,2-3,13,17-20H2,1H3;4-12,14-16H,2-3,13,17-21H2,1H3;4-10,12,15,23H,2-3,11,13-14,16H2,1H3;4-8,10,17H,2-3,9,11H2,1H3;4-8,10-11H,2-3,9H2,1H3;4-8H,2-3,9H2,1H3,(H2,12,13);2-6,9H,1H3/b;;;;;;9-7+
InChIKeyVBOCNYZNBPRWFI-NIJGOKFISA-N
MW2126.67 g/mol
LogP26.30
Rot. Bonds42

About 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine

1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine (PubChem CID 161253262) has the molecular formula C129H144N16O13 and a molecular weight of 2126.67 g/mol. Its IUPAC name is 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine.

Molecular Properties

Compound Name1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine
PubChem CID161253262
Molecular FormulaC129H144N16O13
Molecular Weight2126.67 g/mol
Exact Mass2125.11
IUPAC Name1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine
SMILESCCCC/N=C(\N)c1ccccc1.CCCCn1c(C=O)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)C(=O)c2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)Cc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CNCc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CO)cnc1-c1ccccc1.[H]/N=C(\C)c1ccccc1
InChIInChI=1S/C30H29N3O5.C30H31N3O4.C22H25N3O2.C14H18N2O.C14H16N2O.C11H16N2.C8H9N/c1-2-3-13-33-24(16-31-29(33)22-7-5-4-6-8-22)18-32(17-21-9-11-25-27(14-21)37-19-35-25)30(34)23-10-12-26-28(15-23)38-20-36-26;1-2-3-13-33-25(16-31-30(33)24-7-5-4-6-8-24)19-32(17-22-9-11-26-28(14-22)36-20-34-26)18-23-10-12-27-29(15-23)37-21-35-27;1-2-3-11-25-19(15-24-22(25)18-7-5-4-6-8-18)14-23-13-17-9-10-20-21(12-17)27-16-26-20;2*1-2-3-9-16-13(11-17)10-15-14(16)12-7-5-4-6-8-12;1-2-3-9-13-11(12)10-7-5-4-6-8-10;1-7(9)8-5-3-2-4-6-8/h4-12,14-16H,2-3,13,17-20H2,1H3;4-12,14-16H,2-3,13,17-21H2,1H3;4-10,12,15,23H,2-3,11,13-14,16H2,1H3;4-8,10,17H,2-3,9,11H2,1H3;4-8,10-11H,2-3,9H2,1H3;4-8H,2-3,9H2,1H3,(H2,12,13);2-6,9H,1H3/b;;;;;;9-7+
InChIKeyVBOCNYZNBPRWFI-NIJGOKFISA-N
XLogP26.30
TPSA316.51 Ų
H-Bond Donors4
H-Bond Acceptors27
Rotatable Bonds42
Heavy Atoms158
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002126.67
LogP ≤ 526.30
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine?
The IUPAC name of 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine (CID 161253262) is 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine.
What is the SMILES notation for 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine?
The canonical SMILES for 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine is CCCC/N=C(\N)c1ccccc1.CCCCn1c(C=O)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)C(=O)c2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CN(Cc2ccc3c(c2)OCO3)Cc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CNCc2ccc3c(c2)OCO3)cnc1-c1ccccc1.CCCCn1c(CO)cnc1-c1ccccc1.[H]/N=C(\C)c1ccccc1.
What is the InChIKey of 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine?
The InChIKey is VBOCNYZNBPRWFI-NIJGOKFISA-N. The full InChI is InChI=1S/C30H29N3O5.C30H31N3O4.C22H25N3O2.C14H18N2O.C14H16N2O.C11H16N2.C8H9N/c1-2-3-13-33-24(16-31-29(33)22-7-5-4-6-8-22)18-32(17-21-9-11-25-27(14-21)37-19-35-25)30(34)23-10-12-26-28(15-23)38-20-36-26;1-2-3-13-33-25(16-31-30(33)24-7-5-4-6-8-24)19-32(17-22-9-11-26-28(14-22)36-20-34-26)18-23-10-12-27-29(15-23)37-21-35-27;1-2-3-11-25-19(15-24-22(25)18-7-5-4-6-8-18)14-23-13-17-9-10-20-21(12-17)27-16-26-20;2*1-2-3-9-16-13(11-17)10-15-14(16)12-7-5-4-6-8-12;1-2-3-9-13-11(12)10-7-5-4-6-8-10;1-7(9)8-5-3-2-4-6-8/h4-12,14-16H,2-3,13,17-20H2,1H3;4-12,14-16H,2-3,13,17-21H2,1H3;4-10,12,15,23H,2-3,11,13-14,16H2,1H3;4-8,10,17H,2-3,9,11H2,1H3;4-8,10-11H,2-3,9H2,1H3;4-8H,2-3,9H2,1H3,(H2,12,13);2-6,9H,1H3/b;;;;;;9-7+.
What are the key properties of 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine?
1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine has a molecular weight of 2126.67 g/mol, XLogP of 26.30, 42 rotatable bonds, 4 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1,3-benzodioxol-5-yl)-N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;1-(1,3-benzodioxol-5-yl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]methanamine;N-(1,3-benzodioxol-5-ylmethyl)-N-[(3-butyl-2-phenylimidazol-4-yl)methyl]-1,3-benzodioxole-5-carboxamide;N'-butylbenzenecarboximidamide;3-butyl-2-phenylimidazole-4-carbaldehyde;(3-butyl-2-phenylimidazol-4-yl)methanol;1-phenylethanimine is sourced from PubChem (CID 161253262), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).